Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Trading Statement

11 Nov 2025 07:00

RNS Number : 9353G
4imprint Group PLC
11 November 2025
 

 

 

11 November 2025

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

4imprint today provides a scheduled update on the Group's trading and operations.

 

The Group has delivered a resilient operational and financial performance against the backdrop of volatile macroeconomic conditions in the 10-month period up to the end of October 2025.

 

The Board expects full year Group revenue of not less than $1.32bn, which is at the high end of the current analyst forecast range, and profit before tax of not less than $142m, which is above the upper end of the current analyst forecast range.

 

Group revenue for the first 10 months of 2025 was 2% below the same period in 2024. Order intake has continued to run approximately 3% below prior year with average order values in line with prior year, as the business has traded resiliently through its peak seasonal months. Existing customer order count was flat year to date, reflecting strong and consistent retention rates. New customer order count was down 13% year to date, a continuation of the performance seen in the first half.

 

Gross profit margin has remained strong at just below 33%, as product cost increases due to tariffs are being phased in later than anticipated, while the marketing mix is providing the flexibility we anticipated. As a result, a double-digit operating profit margin has been maintained in the 10-month period.

 

The Group remains highly cash generative and well financed, with a cash balance of $124m at the end of October 2025. The Board has approved a c.$10m capital expenditure for the relocation of its leased downtown Oshkosh, Wisconsin office space to its recently expanded distribution centre which is expected to be completed in mid-2026.

 

The Board is confident that the Group will continue to effectively navigate market conditions, delivering solid financial results while positioning the business to take advantage of opportunities that will present themselves as economic and market conditions improve.

 

For further information, please contact:

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

 

MHP Group

Tel. + 44 (0) 7884 494112

Kevin Lyons-Tarr, Chief Executive Officer

Michelle Brukwicki, Chief Financial Officer

Katie Hunt

Eleni Menikou

Steve Bindas, Director of Investor Relations

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQBLFFEFLZFBK
Date   Source Headline
11th Apr 20134:39 pmRNSDirector Declaration
12th Mar 20131:20 pmRNSHolding(s) in Company
12th Mar 201310:53 amRNSHolding(s) in Company
12th Mar 201310:18 amRNSDirector/PDMR Shareholding
8th Mar 20134:43 pmRNSHolding(s) in Company
8th Mar 20132:34 pmRNSHolding(s) in Company
8th Mar 20132:33 pmRNSHolding(s) in Company
5th Mar 20137:00 amRNSFinal Results
28th Feb 20139:36 amRNSTotal Voting Rights
6th Feb 20135:42 pmRNSBlock Listing Six Monthly Return
5th Feb 201310:02 amRNSHolding(s) in Company
23rd Jan 20137:00 amRNSTrading update and Notice of final results
17th Jan 20132:19 pmRNSApplication for Blocklisting
11th Jan 20139:34 amRNSHolding(s) in Company
10th Jan 20132:16 pmRNSAppointment of joint corporate broker
3rd Jan 201312:52 pmRNSDirector/PDMR Shareholding
14th Dec 201210:41 amRNSHolding(s) in Company
29th Nov 201210:34 amRNSHolding(s) in Company
26th Nov 20125:45 pmRNSEBT purchase
23rd Nov 201210:12 amRNSPension Buy-in
7th Nov 20127:00 amRNSInterim Management Statement
5th Nov 20121:26 pmRNSHolding(s) in Company
18th Oct 201211:01 amRNSNotice of Interim Management Statement
2nd Oct 201210:03 amRNSHolding(s) in Company
2nd Oct 20129:38 amRNSEBT Purchase
18th Sep 201211:21 amRNSHolding(s) in Company
10th Sep 201210:55 amRNSHolding(s) in Company
6th Sep 20123:40 pmRNSEBT Share Purchase
28th Aug 20121:28 pmRNSDirector/PDMR Shareholding
24th Aug 201210:18 amRNSDirector/PDMR Shareholding
23rd Aug 20127:00 amRNSDirector/PDMR Shareholding
2nd Aug 20127:00 amRNSHalf Yearly Report
28th Jun 20129:37 amRNSNotice of Results
26th Jun 20124:51 pmRNSHolding(s) in Company
25th Jun 201212:07 pmRNSHolding(s) in Company
11th Jun 20127:00 amRNSBoard Changes
11th May 20128:40 amRNSHolding(s) in Company
4th May 201212:13 pmRNSResult of AGM
3rd May 201211:00 amRNSInterim Management Statement
30th Apr 20124:28 pmRNSHolding(s) in Company
16th Apr 20123:22 pmRNSAnnual Information Update
16th Apr 201210:22 amRNSHolding(s) in Company
3rd Apr 20124:40 pmRNSSecond Price Monitoring Extn
3rd Apr 20124:35 pmRNSPrice Monitoring Extension
29th Mar 20124:43 pmRNSAnnual Financial Report
23rd Mar 201212:23 pmRNSCompletion of the Sale of Brand Addition
21st Mar 20124:32 pmRNSHolding(s) in Company
19th Mar 20127:00 amRNSDirector/PDMR Shareholding
14th Mar 20123:18 pmRNSResult of Meeting
12th Mar 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.